1. Home
  2. ADAG vs EPSN Comparison

ADAG vs EPSN Comparison

Compare ADAG & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$2.80

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$6.06

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
EPSN
Founded
2011
2005
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
222.2M
187.2M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
ADAG
EPSN
Price
$2.80
$6.06
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $9.91
N/A
AVG Volume (30 Days)
★ 277.3K
108.1K
Earning Date
08-12-2026
11-04-2026
Dividend Yield
N/A
★ 4.36%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.26
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$129.59
N/A
P/E Ratio
★ N/A
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$4.20
52 Week High
$4.85
$6.65

Technical Indicators

Market Signals
Indicator
ADAG
EPSN
Relative Strength Index (RSI) 34.86 52.22
Support Level $2.80 $5.73
Resistance Level $3.19 $6.53
Average True Range (ATR) 0.29 0.23
MACD -0.01 -0.03
Stochastic Oscillator 16.77 49.31

Price Performance

Historical Comparison
ADAG
EPSN

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

Share on Social Networks: